Tumor Lysis Syndrome
📧 Sign up to get email alerts when something new happens for Tumor Lysis Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Pegloticase for the Reduction of Uric Acid in Patients With Tumor Lysis Syndrome [Phase 4]
Phase 4 clinical trial update examining pegloticase for lowering uric acid in patients with tumor lysis syndrome; the study is active but no…
-
CLINICAL_TRIALS trial_result · 2021-06-03Clinical Trial Update: Febuxostat for Tumor Lysis Syndrome Prevention in Hematological Malignancies of Paediatric Patients and Adults [Phase 1, Phase 2]
Clinical trial evaluating febuxostat for prevention of tumor lysis syndrome in pediatric and adult patients with hematological malignancies;…
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy Patients
Completed trial evaluating rasburicase for chemotherapy- or malignancy-induced hyperuricemia in leukemia and lymphoma patients.
-
CLINICAL_TRIALS trial_result · 2014-12-12Clinical Trial Update: Safety and Efficacy of TULY (Rasburicase) in Prevention and Treatment of Malignancy-associated Hyperuricemia [Phase 3]
Phase 3 trial evaluating the safety and efficacy of rasburicase (TULY) for prevention and treatment of malignancy-associated hyperuricemia h…
-
CLINICAL_TRIALS trial_result · 2014-11-03Clinical Trial Update: Febuxostat for Tumor Lysis Syndrome Prevention in Hematologic Malignancies [Phase 3]
Phase 3 trial evaluating febuxostat to prevent tumor lysis syndrome in hematologic malignancies has completed and results have been posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-08-01Clinical Trial Update: Rasburicase in Patients at Risk for Tumor Lysis Syndrome [Phase 2]
This clinical trial update reports results from a Phase 2 study of rasburicase in patients at risk for tumor lysis syndrome, which has compl…
-
CLINICAL_TRIALS trial_result · 2013-01-31Clinical Trial Update: Elitek (Rasburicase) Immuno-Monitoring Study
This clinical trial update reports that the immuno-monitoring study of Elitek (rasburicase) has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-08-01Clinical Trial Update: Pharmacokinetic Evaluation of Rasburicase in Patients With Leukemia and/or Lymphoma at High Risk of TLS [Phase 1, Phase 2]
The study reports pharmacokinetic evaluation of rasburicase in patients with leukemia or lymphoma who are at high risk of tumor lysis syndro…
-
CLINICAL_TRIALS trial_result · 2009-12-31Clinical Trial Update: Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis Syndrome [Phase 3]
Phase 3 trial comparing rasburicase to allopurinol in cancer patients at risk for hyperuricemia and tumor lysis syndrome has completed with …
-
CLINICAL_TRIALS trial_result · 2009-09-25Clinical Trial Update: Rasburicase in Tumor Lysis Syndrome [Phase 4]
Phase 4 trial update indicating completion of rasburicase studies for tumor lysis syndrome with associated hyperuricemia.
-
CLINICAL_TRIALS trial_result · 2008-04-03Clinical Trial Update: Fasturtec TLS Treatment / Prophylysis [Phase 4]
Phase 4 trial of Fasturtec for tumor lysis syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2008-01-28Clinical Trial Update: Rasburicase for Treatment of Hyperuricemia in Children and Adolescence Patients With Tumor Lysis Syndrome [Phase 4]
Phase 4 clinical trial evaluating rasburicase for treatment of hyperuricemia in children and adolescents with tumor lysis syndrome has compl…